| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 958.28B | 866.67B | 759.33B | 680.87B | 603.21B |
| Gross Profit | 311.94B | 274.00B | 232.31B | 202.67B | 170.84B |
| EBITDA | 148.86B | 133.78B | 113.45B | 97.46B | 79.52B |
| Net Income | 76.63B | 71.40B | 60.28B | 50.49B | 43.62B |
Balance Sheet | |||||
| Total Assets | 1.08T | 1.01T | 913.90B | 828.05B | 719.74B |
| Cash, Cash Equivalents and Short-Term Investments | 143.49B | 171.03B | 148.06B | 119.06B | 139.49B |
| Total Debt | 224.74B | 150.43B | 145.25B | 119.33B | 112.05B |
| Total Liabilities | 560.53B | 519.75B | 492.32B | 458.32B | 398.08B |
| Stockholders Equity | 508.88B | 473.28B | 409.88B | 359.97B | 312.31B |
Cash Flow | |||||
| Free Cash Flow | -51.46B | 50.05B | 35.55B | 12.72B | 47.10B |
| Operating Cash Flow | 40.76B | 100.94B | 70.01B | 37.07B | 72.86B |
| Investing Cash Flow | -91.35B | -48.95B | -35.63B | -38.33B | -31.36B |
| Financing Cash Flow | 16.95B | -31.52B | -4.66B | -23.74B | -29.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥80.20B | 4.09 | ― | 3.09% | 10.53% | -25.07% | |
69 Neutral | ¥2.83T | 18.60 | 10.09% | 0.97% | 5.08% | 25.55% | |
67 Neutral | ¥3.23T | 25.09 | 23.30% | 0.71% | 0.02% | 2.33% | |
66 Neutral | ¥2.43T | 22.15 | 16.00% | 1.38% | 10.57% | 7.57% | |
64 Neutral | ¥2.66T | 9.91 | 14.59% | 1.40% | 12.62% | 32.31% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥625.87B | 18.29 | 4.83% | 2.95% | -0.40% | 315.92% |